Cite
HARVARD Citation
Falanga, A. et al. (n.d.). Hypercoagulation screening as an innovative tool for risk assessment, early diagnosis and prognosis in cancer: the HYPERCAN study. Thrombosis research. pp. S55-S59. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Falanga, A. et al. (n.d.). Hypercoagulation screening as an innovative tool for risk assessment, early diagnosis and prognosis in cancer: the HYPERCAN study. Thrombosis research. pp. S55-S59. [Online].